Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity

European Respiratory Journal

Volumn 25, Issue 5, 2005, Pages 864-872

  Westerhof, F J ^a   Zuidhof, A B ^a   Kok, L ^a   Meurs, H ^a   Zaagsma, J ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Airway hyperreactivity; Allergic asthma; Enantiomers; Inflammation; Salbutamol

Indexed keywords

ALLERGEN; HISTAMINE; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG RESPONSE; ENANTIOMER; GUINEA PIG; INFLAMMATORY CELL; LUNG LAVAGE; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ALBUTEROL; ALLERGENS; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DISEASE MODELS, ANIMAL; GUINEA PIGS; ISOMERISM; MALE; SODIUM CHLORIDE; TREATMENT OUTCOME;

EID: 18744407342     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00102203     Document Type: Article

References (27)

1. Vathenen AS, Knox AJ, Higgins BG, Britton JT, Tattersfield AE. Rebound increase in bronchial hyperresponsiveness after treatment with inhaled terbutaline. Lancet 1988; 1: 554-558.
2. Kerrebijn KF, Essen-Zandvliet EE, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and β-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 653-659.
3. Kraan J, Koeter GH, van der Mark TW, Sluiter HJ, de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628-636.
4. 2 agonists. Thorax 1996; 51: 1051-1056.
5. 2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999; 103: 1049-1053.
6. Jokic R, Swystun VA, Davis BE, Cockcroft DW. Regular inhaled salbutamol: effect on airway responsiveness to methacholine and adenosine 5′-monophosphate and tolerance to bronchoprotection. Chest 2001; 119: 370-375.
7. 2-agonists in guinea pig eosinophils. J Allergy Clin Immunol 2000; 106: 896-903.
8. 2-adrenergic receptors. Clin Rev Allergy Immunol 1996; 14: 37-45.
9. Perrin FM, Blum PS, Morley J, Grosclaude M, Chambe MT. Differential responses of asthmatic airways to enantiomers of albuterol. Implications for clinical treatment of asthma. Clin Rev Allergy Immunol 1996; 14: 139-147.
10. Ramsay CM, Cowan J, Flannery E, McLachlan C, Taylor DR. Bronchoprotective and bronchodilator effects of single doses of S-salbutamol, R-salbutamol and racemic salbutamol in patients with bronchial asthma. Eur J Clin Pharmacol 1999; 55: 353-359.
11. Cockcroft DW, Swystun VA. Effect of single doses of (S)-salbutamol, (R)-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine. Thorax 1997; 52: 845-848.
12. Johansson F, Rydberg I, Aberg G, Andersson RG. Effects of albuterol enantiomers on in vitro bronchial reactivity. Clin Rev Allergy Immunol 1996; 14: 57-64.
13. Mitra S, Ugur M, Ugur O, Goodman HM, McCullough JR, Yamaguchi H. (S)-Albuterol increases intracellular free calcium by muscarinic receptor activation and a phospholipase C-dependent mechanism in airway smooth muscle. Mol Pharmacol 1998; 53: 347-354.
14. Cho SH, Hartleroad JY, Oh CK. (S)-albuterol increases the production of histamine and IL-4 in mast cells. Int Arch Allergy Immunol 2001; 124: 478-484.
15. Santing RE, Meurs H, van der Mark TW, et al. A novel method to assess airway function parameters in chronically instrumented, unrestrained guinea-pigs. Pulm Pharmacol 1992; 5: 265-272.
16. Finney MJ, Forsberg KI. Quantification of nasal involvement in a guinea pig plethysmograph. J Appl Physiol 1994; 76: 1432-1438.
17. Santing RE, Olymulder CG, Zaagsma J, Meurs H. Relationships among allergen-induced early and late phase airway obstructions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs. J Allergy Clin Immunol 1994; 93: 1021-1030.
18. Lötvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001; 108: 726-731.
19. Santing RE, Schraa EO, Wachters A, Olymulder CG, Zaagsma J, Meurs H. Role of histamine in allergen-induced asthmatic reactions, bronchial hyperreactivity and inflammation in unrestrained guinea pigs. Eur J Pharmacol 1994; 254: 49-57.
20. Leff AR, Herrnreiter A, Naclerio RM, Baroody FM, Handley DA, Munoz NM. Effect of enantiomeric forms of albuterol on stimulated secretion of granular protein from human eosinophils. Pulm Pharmacol Ther 1997; 10: 97-104.
21. Volcheck GW, Gleich GJ, Kita H. Pro- and anti-inflammatory effects of β-adrenergic agonists on eosinophil response to IL-5. J Allergy Clin Immunol 1998; 101: Suppl. 2, S35.
22. De Boer J, Meurs H, Flendrig L, Koopal M, Zaagsma J. Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br J Pharmacol 2001; 133: 1235-1242.
23. Meurs H, Schuurman FE, Duyvendak M, Zaagsma J. Deficiency of nitric oxide in polycation-induced airway hyperreactivity. Br J Pharmacol 1999; 126: 559-562.
24. Twentyman OP, Finnerty JP, Holgate ST. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis 1991; 144: 782-787.
25. 2-agonist. J Allergy Clin Immunol 1992; 89: 844-849.
26. 2-selective sympathomimetics. Pulm Pharmacol 1994; 7: 367-376.
27. Keir S, Page C, Spina D. Bronchial hyperresponsiveness induced by chronic treatment with albuterol: role of sensory nerves. J Allergy Clin Immunol 2002; 110: 388-394.